A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)

NCT04516291 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

286

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemias
Hyperlipidemias
Hyperlipoproteinemias

Interventions

DRUG: Vupanorsen
DRUG: Placebo

Sponsor

Pfizer

Collaborators

[object Object]